AiutiF., AmmiratiP., FiorilliM., D'AmelioR., FranchiF., CalvaniM., BusincoL.: Immunologic and clinical investigation on a bovine thymic extract. Therapeutic applications in primary immunodeficiencies. Ped. Res., 13; 797 (1979).
2.
AntonaciS., BonomoL.: Effetti in vitro e in vivo degli immunomodulanti. In: Immunologia clinica del fegato e del rene e immunoterapia. Recenti progressi, p. 395. Fradà G. (ed.), Piccin Editore, Padova 1983.
3.
BjorkstenB., LundmarkK. M.: Recurrent bacterial infections in four siblings with neutropenia, eosinophilia, hyper-immunoglobulinemia A, and defective neutrophil chemotaxis. J. Infect. Dis., 133; 63 (1976).
4.
BoyumA.: Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest., 21; Suppl. 96, 77 (1968).
5.
BrandonisioO., AntonaciS., JirilloE., SerlengaE., SansoneL., PiccinnoA., BonomoL.: Non-specific immunity in patients with chronic bacterial prostatitis. EOS - Riv. Immunol. Immunofarmacol., 3; 113 (1985).
6.
BuescherE. S., GallinJ. I.: Disorders of phagocyte functions. In: Fauci A. S., Lichtenstein L. M. (eds.), Current therapy in allergy and immunology, p. 287. B. C. Decker, Philadelphia 1983.
7.
DrachG. W., FairW. R., MearesE. M., StameyT. A.: Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia?J. Urol., 120; 266 (1978).
8.
DrachG. W., NolanP. E.jr.: Chronic bacterial prostatitis: problems in diagnosis and therapy. Urology, 25; 26 (1986).
9.
FalchettiR., CaprinoR.: Immunological aspects of Tp-1 activity. In: Aiuti F., Wigzel H. (eds.), Thymus, thymic hormones and T-lymphocytes, p. 38–213. Academic Press. London, New York 1980.
10.
FowlerJ. E.jr.: Practical approach to bacteriologic investigation of chronic prostatitis. Urology, 26; 17 (1985).
11.
GallinJ. I.: Abnormal phagocyte chemotaxis: pathophysiology, clinical manifestations and management of patients. Rev. Infect. Dis., 3; 1196 (1981).
12.
HatchG. E., NicholsW. K., HillH. R.: Cyclic nucleotide changes in human neutrophils induced by chemoattractants and chemotactic mediators. J. Immunol., 119; 450 (1977).
13.
LehrerR. I., ClineM. J.: Interaction of Candida albicans with human leukocytes and serum. J. Bacteriol., 98; 966 (1969).
14.
MandellL. A.: Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbicidal functions of the polymorphonuclear leukocyte. Rev. Infect. Dis., 4; 683 (1982).
ReinherzE. L., MorettaL., RoperM., BreardJ. M., MingariM. C., CooperM. D., SchlossmanS. F.: Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J. Exp. Med., 151; 961 (1980).
17.
SnydermanR., AltmanL. C., HausmanL. S., MergenhagenS. E.: Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. J. Immunol., 108; 857 (1972).
18.
TseR. L., PhelpsP., UrbanD.: Polymorphonuclear leukocyte motility in vitro. VI. Effect of purine and pyrimidine analogues: possible role of cyclic AMP. J. Lab. Clin. Med., 80; 264 (1972).
19.
TurckM.: Kidney in health and disease. I. Urinary tract infections. Hosp. Pract., 15; 49 (1980).
20.
YamL. T., LiC. Y., CrosbyM. H.: Cytochemical identification of monocytes and granulocytes. Amer. J. Clin. Pathol., 55; 283 (1971).